Weekly Digest – May 2024 Weekly Digest – May 2024 21 May 2024: Enhertu receives expanded indication for breast and lung cancer Daiichi Sankyo Korea and AstraZeneca Korea announced MFDS approval of Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer […]
Weekly Digest – May 2024 Weekly Digest – May 2024 21 May 2024: Pheon Therapeutics Completes $120 million Series B Pheon Therapeutics has completed a $120 million Series B fundraising round to support the development of its differentiated ADC portfolio […]
Weekly Digest – May 2024 Weekly Digest – May 2024 20 May 2024: AstraZeneca places $1.5B bet on end-to-end ADC manufacturing in Singapore AstraZeneca is heavily investing in cancer-fighting technology with a significant manufacturing expansion in Asia Company plans to […]
